Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab‐based treatment response in metastatic colorectal cancer-Reference-Cited by-同舟云学术

Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab‐based treatment response in metastatic colorectal cancer

Published:2014-07-31 Issue:8 Volume:105 Page:996-1001
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Prager Gerald W.¹,Braemswig Kira H.¹,Martel Alexandra¹,Unseld Matthias¹,Heinze Georg²,Brodowicz Thomas¹,Scheithauer Werner¹,Kornek Gabriela¹,Zielinski Christoph C.¹

Affiliation:

1. Clinical Division of Oncology Department of Medicine I and Comprehensive Cancer Center Medical University of Vienna Austria

2. Section for Clinical Biometrics Center for Medical Statistics, Informatics and Intelligent Systems Medical University of Vienna Austria

Funder

Austrian Science Fund

Initiative Krebsforschung

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12451

Reference32 articles.

1. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

2. Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

3. Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

4. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

5. Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal patient selection for yttrium-90 glass plus chemotherapy in the treatment of colorectal liver metastases: additional quality of life, efficacy, and safety analyses from the EPOCH study;The Oncologist;2024-07-10

2. The efficacy and safety of continuous intravenous infusion of rh-endostatin combined with platinum-based doublet chemotherapy for advanced non-small-cell lung cancer;Investigational New Drugs;2024-05-03

3. The application of different machine learning models based on PET/CT images and EGFR in predicting brain metastasis of adenocarcinoma of the lung;BMC Cancer;2024-04-11

4. The efficacy and safety of continuous intravenous infusion of rh-endostatin combined with platinum-based doublet chemotherapy for advanced non-small-cell lung cancer;2023-11-20

5. Deep radiomics-based fusion model for prediction of bevacizumab treatment response and outcome in patients with colorectal cancer liver metastases: a multicentre cohort study;eClinicalMedicine;2023-11